Off Patent Cancer Drug Shows Promise for Herpes Simplex 1
Researchers from the University of Illinois, Chicago report that doxorubicin, a long-established most cancers drug, can block the herpes simplex virus type 1 (HSV-1) in laboratory fashions and in mice. Their findings recommend we would see a brand new remedy possibility alongside current antivirals, like acyclovir, on the cabinets, however not simply but. This drug…